TD Cowen analyst Joshua Jennings raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $70 and keeps a Hold rating on the shares. The firm noted the company offered a favorable multiyear outlook at its annual investor day. The company reiterated its 2024 guidance and introduced 2025 guidance that brackets the Street’s current estimates.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences price target raised to $68 from $63 at Canaccord
- Early notable gainers among liquid option names on December 4th
- Edwards Lifesciences sees FY25 adjusted EPS $2.40-$2.50, consensus $2.47
- Edwards Lifesciences backs FY24 constant currency sales growth of 8%-10%
- Edwards Lifesciences price target raised to $88 from $85 at Barclays